- Trials with a EudraCT protocol (2,415)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,415 result(s) found for: Birth rate.
Displaying page 1 of 121.
EudraCT Number: 2009-014696-52 | Sponsor Protocol Number: 17P-ES-003 | Start Date*: 2009-12-31 | |||||||||||
Sponsor Name:AMAG Pharma USA Inc. | |||||||||||||
Full Title: A PHASE 3B, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML, VERSUS VEHICLE FOR THE PREVENTION OF PRETERM BIRTH IN WOMEN WITH A PREVIOUS SINGLETON ... | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) IT (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001014-15 | Sponsor Protocol Number: S61372 | Start Date*: 2018-06-26 |
Sponsor Name:university hospital leuven | ||
Full Title: Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial | ||
Medical condition: Patients with subfertility having frozen embryos after in vitro fertilization (IVF) or intracytoplasmatic sperm injection (ICSI) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001820-39 | Sponsor Protocol Number: 1984 | Start Date*: 2012-12-14 |
Sponsor Name:Academic medical centre | ||
Full Title: Levothyroxine for euthyroid women with recurrent miscarriage and thyroid autoimmunity : a randomized controlled trial | ||
Medical condition: Thyroid autoimmunity is associated with recurrent miscarriage and preterm birth. Thyroid autoimmunity means there is a normal thyroid function, but presence of thyroid antibodies, thyroid peroxidas... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001069-35 | Sponsor Protocol Number: IIBSP-EDA-2020-18 | Start Date*: 2021-07-06 |
Sponsor Name:Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau | ||
Full Title: Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-IVF): a Randomized Study. | ||
Medical condition: Cumulative live-birth rate. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004545-91 | Sponsor Protocol Number: 59874 | Start Date*: 2017-04-13 |
Sponsor Name:VU University Medical Center, department of reproductive Medicine | ||
Full Title: Continuous use of Oral contraceptives as an alternative for long term Pituitary down-regulation with GnRH agonist prior to IVF/ICSI in Endometriosis patients: a randomised controlled trial (COPIE t... | ||
Medical condition: The research population consists of women with surgically confirmed endometriosis ASRM stage III or IV or endometrioma on transvaginal ultrasound or MRI, scheduled for an IVF/ICSI treatment. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002502-74 | Sponsor Protocol Number: NEU-01-02-01 | Start Date*: 2012-02-14 | ||||||||||||||||
Sponsor Name:Neurophyxia B.V. | ||||||||||||||||||
Full Title: A multi-centre, randomised, double-blind, placebo-controlled Phase II study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of 2-iminobiotin (2-IB) in neonates with gestational... | ||||||||||||||||||
Medical condition: Perinatal asphyxia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: LT (Prematurely Ended) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-002291-42 | Sponsor Protocol Number: 308901 | Start Date*: 2005-03-17 | |||||||||||
Sponsor Name:Schering AG | |||||||||||||
Full Title: Multi-center, open, randomized, dose finding phase II study to investigate for a maximum of three years ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) releasing in vitro 12 ... | |||||||||||||
Medical condition: Contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) HU (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000420-40 | Sponsor Protocol Number: 310442 | Start Date*: 2007-08-08 | |||||||||||
Sponsor Name:Bayer Schering Pharma Oy | |||||||||||||
Full Title: Multi-center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the ultra low dose levonorgestrel contraceptive intra... | |||||||||||||
Medical condition: Contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) HU (Completed) FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000394-30 | Sponsor Protocol Number: 309988 | Start Date*: 2006-08-31 | |||||||||||
Sponsor Name:Schering Oy | |||||||||||||
Full Title: Multicenter study to investigate the bleeding profile and the insertion easiness in women inserted with a second consecutive MIRENA for contraception or menorrhagia | |||||||||||||
Medical condition: Contraception or menorrhagia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IE (Completed) FI (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004491-17 | Sponsor Protocol Number: REMODEL | Start Date*: 2021-03-31 |
Sponsor Name:UZ Brussel | ||
Full Title: Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. | ||
Medical condition: progesterone as luteal phase supplementation in frozen embryo transfer cycles | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017245-64 | Sponsor Protocol Number: OG09/9146 | Start Date*: 2010-09-07 |
Sponsor Name:Leeds Teaching Hospitals NHS Trust | ||
Full Title: The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. | ||
Medical condition: Polycystic Ovary Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2022-003415-29 | Sponsor Protocol Number: 2.0 | Start Date*: 2023-04-03 | |||||||||||
Sponsor Name:Leiden University Medical Centre | |||||||||||||
Full Title: The effect of antenatal acetaminophen administration on breathing effort of premature infants at birth: a pilot study | |||||||||||||
Medical condition: Pregnant women expected to deliver between 24 and 30 weeks' gestation | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000994-96 | Sponsor Protocol Number: 214725 | Start Date*: 2021-07-14 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A Phase III, double-blind, randomized, placebo-controlled study to evaluate the safety, reactogenicity and immune response of a single intramuscular dose of unadjuvanted RSV Maternal vaccine, in hi... | ||
Medical condition: High risk pregnant women (prevention of RSV-associated lower respiratory tract illnesses (LRTIs) in infants) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: FI (Completed) ES (Temporarily Halted) IT (Completed) Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-005696-17 | Sponsor Protocol Number: 1645-CI-058 | Start Date*: 2013-06-18 |
Sponsor Name:Instituto de Investigacion Sanitaria La Fe | ||
Full Title: Multicenter, randomized, blinded clinical study comparing early use of total body moderate hypothermia plus topiramate or placebo in asphyxiated newborn infants evolving to moderate-to-severe hypox... | ||
Medical condition: Asphyxiated newborn infants evolving to moderate-to-severe hypoxic ischemic encephalopathy | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001137-41 | Sponsor Protocol Number: 666 | Start Date*: 2018-06-26 |
Sponsor Name:Hvidovre Hospital. Dep of Respiratory Medicine | ||
Full Title: Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the sixth day o... | ||
Medical condition: infertility within female asthma patients as a result of systemic inflamation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004160-58 | Sponsor Protocol Number: CHASAP | Start Date*: 2021-06-11 | ||||||||||||||||
Sponsor Name:Centre hospitalier intercommunal de Créteil | ||||||||||||||||||
Full Title: Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial | ||||||||||||||||||
Medical condition: Pregnant women with chronic hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004641-16 | Sponsor Protocol Number: RG_18-272 | Start Date*: 2020-02-14 | |||||||||||||||||||||||||||||||
Sponsor Name:University of Birmingham | |||||||||||||||||||||||||||||||||
Full Title: Letrozole or Clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome: a 2x2 factorial design randomised trial (The LOCI trial) | |||||||||||||||||||||||||||||||||
Medical condition: Ovulation induction for women suffering from polycystic ovary syndrome | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Under 18, Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000599-33 | Sponsor Protocol Number: LWH0646 | Start Date*: 2006-08-21 |
Sponsor Name:Liverpool Women's NHS Foundation Trust | ||
Full Title: Duration of luteal phase support with progesterone pessaries to improve the success rate in assisted reproduction cycles. A prospective randomised control trial. | ||
Medical condition: Women undergoing assisted conception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005180-16 | Sponsor Protocol Number: FFIS/2015/02/EV | Start Date*: 2016-09-08 | |||||||||||
Sponsor Name:Fundación para la Formación e Investigación Sanitaria | |||||||||||||
Full Title: Early vaginal progesterone for the prevention of spontaneous preterm birth in twins: A randomised, placebo controlled, double-blinded trial. | |||||||||||||
Medical condition: Spontaneous preterm birth in twin pregnancies. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) ES (Completed) BG (Completed) IT (Ongoing) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000106-29 | Sponsor Protocol Number: T5/2013 | Start Date*: 2013-03-19 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: GnRH analog as a luteal phase support in frozen-thawed embryo transfer cycles. A Pilot study | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
